The Clinical Impact of E-PRF and H-PRF on Healing After Mandibular Third Molar Surgery
Evaluation of Soft and Hard Tissue Healing After Impacted Mandibular Third Molar Surgery With the Use of E-PRF and H-PRF - a Randomized Controlled Clinical Study
1 other identifier
interventional
61
1 country
1
Brief Summary
This clinical trial aims to compare the effect of platelet concentrates E-PRF and H-PRF on soft and hard tissue healing in healthy individuals after lower third molar surgery. The main questions it aims to answer are: Do E-PRF and H-PRF reduce complications after third molar surgery? Do E-PRF and H-PRF improve soft tissue healing after third molar surgery? Do E-PRF and H-PRF improve hard tissue healing after third molar surgery? Participants will be divided into 2 study groups and one control group. Third molar surgery will be performed according to standard protocol. In study groups, dentoalveolar defects will be filled with E-PRF and H-PRF which are products of centrifugation of the patient's blood without additives. Soft tissue and hard tissue healing will be compared between the groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started May 2021
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 21, 2021
CompletedFirst Submitted
Initial submission to the registry
February 15, 2023
CompletedFirst Posted
Study publicly available on registry
March 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2024
CompletedAugust 9, 2024
August 1, 2024
2.7 years
February 15, 2023
August 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
The impact of E-PRF vs H-PRF vs Control on soft tissue healing
Soft tissue healing evaluation will be done by modified Landry, Turnbull and Howley healing index. For each post-extraction site, the following parameters will be evaluated by dichotomic scale (0/1): tissue color, response to palpation, presence of granulation tissue, epithelialization of incision margins and suppuration.
3 days
The impact of E-PRF vs H-PRF vs Control on soft tissue healing
Soft tissue healing evaluation will be done by modified Landry, Turnbull and Howley healing index. For each post-extraction site, the following parameters will be evaluated by dichotomic scale (0/1): tissue color, response to palpation, presence of granulation tissue, epithelialization of incision margins and suppuration.
7 days
The impact of E-PRF vs H-PRF vs Control on bone regeneration
Bone healing will be evaluated by comparing digital OPGs i.e. radiographic bone densitiy profiles in extraction sockets will be compared.
1 month
The impact of E-PRF vs H-PRF vs Control on bone regeneration
Bone healing will be evaluated by comparing digital OPGs i.e. radiographic bone densitiy profiles in extraction sockets will be compared.
3 months
Secondary Outcomes (7)
The impact of E-PRF vs H-PRF vs Control on periodontal pocket depth
1 month
The impact of E-PRF vs H-PRF vs Control on periodontal pocket depth
3 months
The impact of E-PRF vs H-PRF vs Control on postoperative trismus
3 days
The impact of E-PRF vs H-PRF vs Control on postoperative trismus
7 days
The impact of E-PRF vs H-PRF vs Control on postoperative swelling
3 days
- +2 more secondary outcomes
Study Arms (3)
E-PRF
EXPERIMENTALAfter the impacted mandibular third molar has been surgically removed E-PRF is placed in the dentoalveolar defect and the wound is primarily closed.
H-PRF
EXPERIMENTALAfter the impacted mandibular third molar has been surgically removed H-PRF is placed in the dentoalveolar defect PRF made with horizontal centrifuge and the wound is primarily closed.
CONTROL
NO INTERVENTIONAfter the impacted mandibular third molar has been surgically removed, the wound is primarily closed.
Interventions
Platelet-rich fibrin is an autologous biomaterial originating from human blood following centrifugation without additives that contains supraphysiological doses of growth factors. it serves as a biological healing matrix by supporting cell migration and cytokine release. H-PRF is obtained by horizontal centrifugation using (Bio-PRF) centrifuge on 700 g force for 8 minutes. This way the cells separate much more efficiently throughout the entire membrane/clot.
Platelet-rich fibrin is an autologous biomaterial originating from human blood following centrifugation without additives that contains supraphysiological doses of growth factors. In order to extend its resorption period heating method is used. After centrifugation of blood using (Bio-PRF) centrifuge on 700 g force for 8 minutes top layer is heated for 10 minutes at 75°C in BIO-Heat device. When cooled it is mixed with cell rich buffy coat. This way PRF with extended life is obtained.
Eligibility Criteria
You may qualify if:
- Orthodontic indication for impacted mandibular third molar surgery
- Physical status I according to the guidelines of the American Society of Anesthesiologists (ASA)
You may not qualify if:
- Presence of systemic disease
- Presence of a condition that affects fibrin clot formation
- History of radiation therapy or chemotherapy
- Allergy to penicillin
- Oral contraceptive usage
- Smoking habit
- Status of pregnancy or lactation
- Presence of any acute local infection
- Missing the adjacent second molar or indicated for extraction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Amila Haskiclead
Study Sites (1)
Faculty of Dentistry with Dental Clinical Center
Sarajevo, Federation of Bosnia and Herzegovina, 71000, Bosnia and Herzegovina
Study Officials
- PRINCIPAL INVESTIGATOR
Amila Haskic
University of Sarajevo
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 15, 2023
First Posted
March 17, 2023
Study Start
May 21, 2021
Primary Completion
January 30, 2024
Study Completion
January 30, 2024
Last Updated
August 9, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share